{"log_id": 3837106860487818067, "direction": 0, "words_result_num": 44, "words_result": [{"probability": {"variance": 4.7e-05, "average": 0.995831, "min": 0.973624}, "location": {"width": 536, "top": 141, "height": 69, "left": 117}, "words": "在的交叉效应,须在1-2周内严密观察患者的低血糖现象"}, {"probability": {"variance": 1e-06, "average": 0.999307, "min": 0.996307}, "location": {"width": 475, "top": 177, "height": 65, "left": 126}, "words": "【孕妇及哺乳期妇女用药】孕妇、哺乳期妇女禁用"}, {"probability": {"variance": 0.00036, "average": 0.994586, "min": 0.901416}, "location": {"width": 835, "top": 184, "height": 92, "left": 129}, "words": "【儿童用药】尚无格列美脲对儿童患者的安全性和有效性的研究,故不推荐儿童应用本品"}, {"probability": {"variance": 8e-06, "average": 0.997997, "min": 0.989474}, "location": {"width": 849, "top": 217, "height": 91, "left": 131}, "words": "【老年用药】老年人、虚弱和营养不良的患者或肝肾功能不全的患者,初始剂量、剂量上调"}, {"probability": {"variance": 8.8e-05, "average": 0.995135, "min": 0.96055}, "location": {"width": 482, "top": 277, "height": 64, "left": 126}, "words": "和维持剂量应慎重,应遵医嘱,以避免低血糖反应"}, {"probability": {"variance": 7.1e-05, "average": 0.996315, "min": 0.959832}, "location": {"width": 790, "top": 284, "height": 90, "left": 136}, "words": "【药物相互作用】服用本品的病人需服用或停服其他药物时,可能会导致血糖的改变"}, {"probability": {"variance": 0.004712, "average": 0.985504, "min": 0.583092}, "location": {"width": 781, "top": 317, "height": 86, "left": 173}, "words": "根据使用本品的经验及基于其他磺酰类药物的认识,应考虑到以下药物的相互作用"}, {"probability": {"variance": 0.001024, "average": 0.990833, "min": 0.819941}, "location": {"width": 816, "top": 346, "height": 90, "left": 174}, "words": "当与下列具有增强降血糖作用的某个药物合用时,可能会导致低血糖发生,例如:胰岛"}, {"probability": {"variance": 0.000374, "average": 0.992003, "min": 0.8954}, "location": {"width": 855, "top": 381, "height": 91, "left": 135}, "words": "素、其他降糖药、ACE抑制剂、别嘌呤醇、促蛋白合成类固醇及雄激素、氯霉素、香豆素"}, {"probability": {"variance": 0.000129, "average": 0.994488, "min": 0.94517}, "location": {"width": 854, "top": 418, "height": 84, "left": 138}, "words": "衍生物、环磷酰胺、双异丙吡胺、氟苯丙胺、苯吡胺醇、纤维素衍生物、氟苯氧丙胺、胍乙"}, {"probability": {"variance": 0.007184, "average": 0.970475, "min": 0.587144}, "location": {"width": 854, "top": 448, "height": 89, "left": 139}, "words": "啶、异环磷酰胺、MAO抑制剂、环氯苯咪唑、对氨水杨酸、已酮可可碱(胃肠外高剂量)、"}, {"probability": {"variance": 0.00014, "average": 0.994767, "min": 0.92869}, "location": {"width": 847, "top": 482, "height": 87, "left": 141}, "words": "保泰松、炎爽痛、羟基保泰松、丙璜舒、喹诺酮类、水杨酸、苯磺唑酮、磺胺类、四环素族"}, {"probability": {"variance": 0.000483, "average": 0.992878, "min": 0.879033}, "location": {"width": 801, "top": 546, "height": 82, "left": 189}, "words": "当与下列具有减弱降血糖作用的某个药物合用时,可能会引起高血糖,例如:乙酰唑胺"}, {"probability": {"variance": 0.00015, "average": 0.991294, "min": 0.958748}, "location": {"width": 238, "top": 556, "height": 43, "left": 146}, "words": "三乙氯唑、氯乙环磷酰胺"}, {"probability": {"variance": 0.001435, "average": 0.992389, "min": 0.757386}, "location": {"width": 855, "top": 577, "height": 89, "left": 150}, "words": "巴比妥类、皮质类固醇、氯甲苯噻嗪、利尿药、肾上腺素和拟交感神经药物、高血糖素、轻"}, {"probability": {"variance": 0.002184, "average": 0.98491, "min": 0.724061}, "location": {"width": 856, "top": 610, "height": 88, "left": 151}, "words": "泻药(长期使用时)、烟酸(高剂量)、雌激素和孕激素、吩噻嗪、苯妥英、利福平、甲状腺"}, {"probability": {"variance": 2e-06, "average": 0.989007, "min": 0.987707}, "location": {"width": 48, "top": 701, "height": 28, "left": 154}, "words": "激素"}, {"probability": {"variance": 0.000138, "average": 0.996371, "min": 0.942364}, "location": {"width": 591, "top": 690, "height": 69, "left": 195}, "words": "H2受体拮抗剂、氯压定和利血平可能会增强或减弱降血糖作用"}, {"probability": {"variance": 0.003637, "average": 0.982389, "min": 0.636018}, "location": {"width": 808, "top": 709, "height": 83, "left": 203}, "words": "β-阻滞剂可降低耐糖量,可导致糖尿病病人代谢控制恶化。另外,β-阻滞剂还可使病"}, {"probability": {"variance": 0.000468, "average": 0.99148, "min": 0.896589}, "location": {"width": 455, "top": 769, "height": 58, "left": 159}, "words": "人容易出现低血糖(由于使反向调节作用受损)"}, {"probability": {"variance": 0.000147, "average": 0.995368, "min": 0.932626}, "location": {"width": 812, "top": 773, "height": 84, "left": 204}, "words": "在抗交感神经药物如β阻滞剂、氯压定、胍乙啶和利血平的作用下,对低血糖的肾上"}, {"probability": {"variance": 5e-06, "average": 0.997741, "min": 0.993244}, "location": {"width": 352, "top": 839, "height": 53, "left": 165}, "words": "腺素反向调节作用可能会减弱或缺乏"}, {"probability": {"variance": 7e-06, "average": 0.997913, "min": 0.988399}, "location": {"width": 585, "top": 853, "height": 70, "left": 210}, "words": "无法预料急性和慢性饮酒对本品的降血糖作用是增强还是减弱"}, {"probability": {"variance": 5.1e-05, "average": 0.995525, "min": 0.971839}, "location": {"width": 375, "top": 899, "height": 58, "left": 209}, "words": "香豆素衍生物的作用可能是增强或减弱"}, {"probability": {"variance": 0.032097, "average": 0.913139, "min": 0.430594}, "location": {"width": 815, "top": 900, "height": 95, "left": 211}, "words": "阿司匹林(1g天三次)和格列美脲联合应用可到AC降低34%因"}, {"probability": {"variance": 0.021471, "average": 0.910762, "min": 0.363958}, "location": {"width": 857, "top": 934, "height": 96, "left": 172}, "words": "此,平均CL/f升高34%,平均Cmax降低形糖C肽水平不受影响,也未见低"}, {"probability": {"variance": 0.00908, "average": 0.966584, "min": 0.623407}, "location": {"width": 846, "top": 968, "height": 95, "left": 172}, "words": "血糖症状出现。临床试验的综合资料没有证据示当阿司匹林和其他水杨酸盐联合使用时"}, {"probability": {"variance": 0.00407, "average": 0.968183, "min": 0.665735}, "location": {"width": 809, "top": 1038, "height": 82, "left": 223}, "words": "单剂量口服4mg格列美脲无论和西米替丁(800mg,一天一次)还是和雷尼替丁(50mg"}, {"probability": {"variance": 0.001042, "average": 0.988618, "min": 0.877021}, "location": {"width": 287, "top": 1042, "height": 48, "left": 178}, "words": "会产生临床上有害的相互作用"}, {"probability": {"variance": 0.000114, "average": 0.995082, "min": 0.943}, "location": {"width": 851, "top": 1068, "height": 86, "left": 184}, "words": "一天二次)联用,对格列美脲的吸收和代谢都无显著影响,其低血糖症状无差异临床试验"}, {"probability": {"variance": 0.006407, "average": 0.978511, "min": 0.572426}, "location": {"width": 773, "top": 1105, "height": 83, "left": 185}, "words": "的综合资料没有证据显示和H2受体拮抗剂联合使用会产生临床上有害的相互作用"}, {"probability": {"variance": 0.02438, "average": 0.934246, "min": 0.432743}, "location": {"width": 809, "top": 1133, "height": 86, "left": 231}, "words": "心得安(40mg一天三次)和格列美脲的联合使用,会显著提高格列美脲的 CHPALIAUC"}, {"probability": {"variance": 0.005698, "average": 0.972997, "min": 0.602174}, "location": {"width": 854, "top": 1166, "height": 88, "left": 189}, "words": "和T12,分别达到23%22%和15%,降低CL/f达18%,然而,尿中M和M回收率无变"}, {"probability": {"variance": 0.007202, "average": 0.98102, "min": 0.466051}, "location": {"width": 854, "top": 1201, "height": 87, "left": 191}, "words": "化在健康人接受心得安和安慰剂,对于格列美脉的药效学反应几乎一样。2型糖尿病患者"}, {"probability": {"variance": 0.000332, "average": 0.995102, "min": 0.886733}, "location": {"width": 852, "top": 1235, "height": 83, "left": 193}, "words": "的临床试验综合资料没有证据显示和β受体阻滞剂联合使用会产生临床上的有害相互作"}, {"probability": {"variance": 0.014032, "average": 0.959783, "min": 0.52698}, "location": {"width": 654, "top": 1279, "height": 70, "left": 197}, "words": "用。然而,如果应用β受体阻滞剂时应告诚患者有发生低血糖的可能"}, {"probability": {"variance": 0.000351, "average": 0.992308, "min": 0.914038}, "location": {"width": 812, "top": 1297, "height": 81, "left": 238}, "words": "格列美脲(4mg一天一次)和单剂量(25mg)消旋华法林联合使用,对于健康人不改"}, {"probability": {"variance": 5.8e-05, "average": 0.997002, "min": 0.951983}, "location": {"width": 841, "top": 1330, "height": 83, "left": 200}, "words": "变右旋和左旋华法林对映体的药代动力学特征。据观察华法林的血清蛋白结合率没有变化"}, {"probability": {"variance": 0.003622, "average": 0.987456, "min": 0.617499}, "location": {"width": 854, "top": 1359, "height": 89, "left": 200}, "words": "格列美脲的治疗会产生轻微的但统计学上有显著意义的华法林药效学反应的降低凝血酶原"}, {"probability": {"variance": 0.000169, "average": 0.994966, "min": 0.918947}, "location": {"width": 854, "top": 1394, "height": 92, "left": 203}, "words": "时间(PT)曲线下平均面积和最大凝血酶原时间(PT)值降低在格列美脲治疗中非常小(分"}, {"probability": {"variance": 0.004792, "average": 0.959805, "min": 0.707501}, "location": {"width": 314, "top": 1466, "height": 56, "left": 206}, "words": "别为3.3%和9.9%),无临床意义"}, {"probability": {"variance": 0.001098, "average": 0.989295, "min": 0.8243}, "location": {"width": 811, "top": 1466, "height": 85, "left": 250}, "words": "正常人服用2mg格列美脲对于血糖、胰岛素、C肽和血浆胰高血糖素的反应在联合应"}, {"probability": {"variance": 0.000407, "average": 0.991458, "min": 0.890696}, "location": {"width": 856, "top": 1502, "height": 83, "left": 209}, "words": "用雷米普利(一种ACE抑制剂)5mg一天一次时不受影响,未见低血糖症状。2型糖尿病"}, {"probability": {"variance": 0.00191, "average": 0.983559, "min": 0.778442}, "location": {"width": 854, "top": 1534, "height": 82, "left": 211}, "words": "患者的临床试验综合资料未有证据显示与ACEI的联合应用会产生临床有害的药物相互作"}], "language": -1}